Skip to main content

Pharvaris N.V.

PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001830487

In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Pharvaris N.V. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of PHVS: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders5154+3
Shares45.0M44.6M−401.3K (−0.9%)
Value$834.2M$855.8M+$21.6M (+2.6%)

New holders (9)

Institutions that held Pharvaris N.V. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to PHVS in Q4 2024
InstitutionSharesValue% of portfolio
Woodline Partners LP44,514$853.3K0.01%
Palumbo Wealth Management LLC10,221$195.9K0.07%
Point72 Asset Management, L.P.7,921$151.8K0.00%
KLP Kapitalforvaltning AS5,800$111.2K0.00%
Cubist Systematic Strategies, LLC3,336$63.9K0.00%
Police & Firemen's Retirement System of New Jersey2,369$45.4K0.00%
Citigroup Inc543$10.4K0.00%
BNP Paribas Arbitrage, SA100$1.92K0.00%
SBI Securities Co., Ltd.11$2110.00%

Sold out (6)

Institutions that held Pharvaris N.V. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of PHVS in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
EcoR1 Capital, LLC900,000$16.7M
Marshall Wace, LLP59,014$1.09M
Jane Street Group, LLC28,418$526.3K
Crestline Management, LP15,819$293.0K
Ghisallo Capital Management LLC11,249$208.3K
ADAR1 Capital Management, LLC2,000$37.0K